Alice Fung, MD Oregon Health and Science University

Similar documents
Hepatic Imaging: What Every Practitioner Should Know

Radiology of hepatobiliary diseases

US LI-RADS v2017 CORE

HEPATO-BILIARY IMAGING

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

The Focal Hepatic Lesion: Radiologic Assessment

Computed tomography. Department of Radiology, University Medical School, Szeged

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Imaging of liver and pancreas

State of the Art Imaging for Hepatic Malignancy: My Assignment

Liver Ultrasound - Beyond the Basics. Pamela Parker Lead Sonographer

Modern liver imaging techniques - A new era in liver ultrasound

Portal Venous Thrombosis: Tumor VS Bland Thrombus

IMAGING OF LIVER, BILIARY TREE, PANCREAS

Innovations in HCC Imaging: MDCT/MRI

MRI of the Hepatobiliary System

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

Elastography in the. technically difficult patient. EPIQ ultrasound system. Ultrasound

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Acknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions

Liver Cancer And Tumours

Malignant Focal Liver Lesions

MRI OF FOCAL LESIONS IN

Abdomen Sonography Examination Content Outline

Objectives. LI-RADS v2017. Working Groups. Cynthia Santillan. Released October 2014 Diagnosis. Screening/ Surveillance. Diagnosis

Liver imaging takes a step forward with Ingenia

Financial Disclosure

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

MRI Abdomen Protocol Pancreas/MRCP with Contrast

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Case Study: #3: Gallbladder Carcinoma?

Interesting Cases from Liver Tumor Board. Jeffrey C. Weinreb, M.D.,FACR Yale University School of Medicine

Anatomical and Functional MRI of the Pancreas

Imaging of common diseases of hepatobiliary and GI system

Vascular Imaging in the Pediatric Abdomen. Jonathan Swanson, MD

Complete Summary GUIDELINE TITLE. Liver lesion characterization. BIBLIOGRAPHIC SOURCE(S)

CT & MRI of Benign Liver Neoplasms Srinivasa R Prasad

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Essentials of Clinical MR, 2 nd edition. 65. Benign Hepatic Masses

Abdominal Ultrasound. Diane Hallinen, MD. Bloodroot

Simplifying liver assessment in internal medicine

GASTROINTESTINAL IMAGING STUDY GUIDE

Liver MRI in 30 minutes

Radiologic Imaging Magnetic Resonance Imaging (MRI)

Hepatobiliary Ultrasound Rimon Bengiamin, MD, RDMS Assistant Clinical Professor Director of Emergency Ultrasound UCSF Fresno. Objectives. Why?

Diffuse Liver Disease:

Pediatric Hepatobiliary, Pancreatic & Splenic US

Hepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Abdomen and Retroperitoneum Ultrasound Protocols

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1

Biliary Ultrasonography Kathleen O Brien MD MPH RDMS Kaiser Permanente South Sacramento

Hepatocellular Carcinoma: Diagnosis and Management

iu22 Liver Shear Wave ElastPQ

Evaluation of Diffuse Liver Diseases Using Conventional Ultrasound

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Normal Sonographic Anatomy

Non-Invasive Testing for Liver Fibrosis

IT 의료융합 1 차임상세미나 복부질환초음파 이재영

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING:

Contrast Enhanced Ultrasound of Parenchymal Masses in Children

Cholangiocarcinoma (Bile Duct Cancer)

Imaging iconography of gallbladder cancer. Assessment by CT.

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Body MRI from the Liver to the Bladder

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation

Liver, Pancreas and Biliary System. Wirana Angthong, M.D.

My Patient Has Abdominal Pain PoCUS of the Biliary Tract and the Urinary Tract

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Gemstone Spectral Imaging quantifies lesion characteristics for a confident diagnosis

Abdominal Imaging - 9 Topics in 90 min

Liver imaging the revolution

Recently role of non-invasive diagnostics methods

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

ACG Clinical Guideline: Diagnosis and Management of Focal Liver Lesions

Chief Complain. Liver lesion found in routine health check 41 days ago

Liver Specific MRI using Gd-EOB-DTPA Disodium (Primovist) Effects Change in Management of Indeterminate Liver Lesions.

Soft Tissue Tumour & Sarcoma Imaging Guidelines 2012

How to integrate surgery in the treatment of patients with liver-only metastatic disease

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Appropriate Imaging Tests Lead to Meaningful Results. Dr. Richard Wasley May 2011

Ankur A. Gupta 1, Danny C. Kim, Glenn A. Krinsky, Vivian S. Lee

LI-RADS Reporting. Chapter 14. Primary Authors. Contributing Authors. Memorial Sloan Kettering Cancer Center

Guidelines, Policies and Statements D5 Statement on Abdominal Scanning

Compute-aided Differentiation of Focal Liver Disease in MR Imaging

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

RADIOLOGY TEACHING CONFERENCE

Approach to the Patient with Liver Disease

Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads

Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center

Workup of a Solid Liver Lesion

Radiological Reasoning: Incidentally Discovered Liver Mass

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Surveillance for Hepatocellular Carcinoma

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

Gastrointestinal tract

US in non-traumatic acute abdomen. Lalita, M.D. Radiologist Department of radiology Faculty of Medicine ChiangMai university

Transcription:

Alice Fung, MD Oregon Health and Science University

Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual s financial interest are not related to the content of the activity. The speaker/planner Atif Zaman, MD MPH have no relevant financial relationships to disclose. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose.

Ultrasound Computed Tomography Magnetic Resonance Imaging Nuclear Medicine

Uses high frequency sound waves and their echoes Advantages: Noninvasive Excellent screening tool Relatively inexpensive Disadvantages: Low sensitivity High FN rates for detection of liver metastases Operator dependent

Indications: RUQ pain Bile duct obstruction Gallstones Abnormal LFT s Assess for underlying liver disease, ie steatosis Suspected liver masses Cyst versus solid lesion Hepatic Vasculature Patency of hepatic and portal venous systems Flow direction Hepatopedal: toward the liver Hepatofugal: away from the liver Consider requesting dopplers when examining the liver

Ultrasound for HCC Screening Goal: detect HCC at early stage when amenable to curative therapy US every 6 months Sensitivity 65% US + AFP: 90% sensitivity for early stage HCC

Ultrasound Radiology Speak Patient Scanning Characteristics Hyperechoic and Heterogeneous hepatic parenchyma Fatty infiltration or fibrosis Hepatocellular dysfunction Hypo or Hyper-echoic lesions If not a cyst, then further work up is necessary! US LI-RADS

US Liver Imaging Reporting and Data System (LI-RADS) US Category US-1: Negative US-2: Subthreshold (<10 mm) US-3: Positive (>/= 10 mm) US Visualization Score US-A: No or minimal limitations US-B: Moderate limitations US-C: Severe limitations

Uses X-rays to acquire images displayed in axial, sagittal, and coronal planes Advantages: Quick exam with short breath-holds Relatively available High spatial resolution Disadvantages Ionizing radiation Iodinated IV contrast is mandatory Consider MRI if Iodinated IV contrast cannot be administered Except for specific scenarios, noncontrast CT to evaluate for liver pathologies is insufficient

Indications: Characterize lesion seen by ultrasound or single-phase CT Screening in patients whose ultrasounds are no longer diagnostic (cirrhotic patients) Treatment response Evaluation of degree of portal hypertension Ascites Varices Vascular patency, including TIPS Post-transplant complications

Hepatic Enhancement Noncontrast Arterial Phase (25 secs) Portal Venous Phase (70 secs) Equilibrium (Delayed) Phase

HCC Supplied by hepatic artery Enhance during the arterial phase before normal liver parenchyma Normal liver parenchyma Supplied by portal veins Maximally enhances during the portal venous phase

In contrast, hemangiomas exhibit slow, progressive enhancement.

Uses magnetic properties of protons Advantages: Spatial resolution High soft tissue contrast resolution Very sensitive No radiation or iodinated contrast Disadvantages Costly Not as readily available Longer exam times than CT Acquisition time Patient cooperation with exam Claustrophobia Longer breath-holds Gadolinium contrast

Indications Patients allergic to iodinated contrast Lesion detection & characterization Vascular patency Biliary tree assessment Similar indications as with CT Reliance on multiphase post contrast imaging and T1 and T2-weighted sequences for lesion detection and characterization

CT/MR Radiology Speak Appearance of cirrhosis Nodular hepatic contour Shrunken liver Left lateral segment/caudate lobe hypertrophy Expanded gallbladder fossa

Evidence of portal hypertension MPV diameter >12 mm Spleen size >12 cm Ascites Varices Recanalized paraumbilical vein Gallbladder wall edema often seen and not to be suggestive of cholecystitis Hypoalbuminemia Reactive to hepatitis

Perfusional abnormality/shunt Cavernous transformation of the portal vein Replaced hepatic arteries

Confluent fibrosis Bridging fibrosis

Geographic hepatic steatosis

MRI and Fat Evaluation

MRI and Iron Evaluation

Liver Imaging Reporting and Data System (LI-RADS) Lesions versus observations Observations assigned category codes based on size and suspicion of HCC LR-NC: Noncategorized LR-TIV: Tumor in Vein, irregardless of type of tumor LR1: definitely benign LR2: probably benign LR3: intermediate probability of HCC LR4: probably HCC LR5: definitely HCC near 100% PPV LR-M: Malignancy, not specifically HCC

Thank You!